Discovery of novel 1,2,3-triazole derivatives as ido1 inhibitors

HIGHLIGHTS

• who: Xixi Hou and collaborators from the The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China have published the paper: Discovery of Novel 1,2,3-triazole Derivatives as IDO1 Inhibitors, in the Journal: Pharmaceuticals 2022, 1316 of /2022/
• what: The research has resulted in a series of novel IDO1 inhibitors which is beneficial to the development of drugs targeting IDO1 in numerous cancer diseases. In this study, three series of compounds containing a urea structure and 1,2,3-triazole structure were designed, among which . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.